Omenn G S, Smith L T
J Clin Invest. 1978 Aug;62(2):235-40. doi: 10.1172/JCI109121.
Kinetic and pharmacologic properties of uptake of serotonin and dopamine by normal human platelets have been investigated to test whether platelets can be employed as a model system for the reuptake of serotonin and dopamine in brain. Uptake of serotonin into platelets closely resembles reuptake of serotonin into serotonergic neurons. In contrast, uptake of dopamine into platelets appears to be mediated inefficiently via the specific serotonin uptake mechanism, based upon several lines of evidence. Serotonin and dopamine compete with each other, Antidepressant drugs, which are competitive inhibitors of uptake of both of these neurotransmitters, act at the same concentration of drug despite large differences in the Km values. Serotonin antagonists inhibit both serotonin and dopamine uptake. Finally, a serotonin-specific uptake inhibitor (fluoxetine) blocks dopamine, as well as serotonin, uptake.
已经对正常人血小板摄取5-羟色胺和多巴胺的动力学及药理学特性进行了研究,以测试血小板是否可作为大脑中5-羟色胺和多巴胺再摄取的模型系统。血小板摄取5-羟色胺与5-羟色胺能神经元摄取5-羟色胺非常相似。相比之下,基于多方面证据,血小板摄取多巴胺似乎是通过特定的5-羟色胺摄取机制低效介导的。5-羟色胺和多巴胺相互竞争,抗抑郁药物是这两种神经递质摄取的竞争性抑制剂,尽管它们的Km值有很大差异,但在相同药物浓度下起作用。5-羟色胺拮抗剂抑制5-羟色胺和多巴胺的摄取。最后,一种5-羟色胺特异性摄取抑制剂(氟西汀)可阻断多巴胺以及5-羟色胺的摄取。